戻る Agenda
Breakfast Plenary Session: Emergency Single Patient IND for Oligonucleotide Therapy of a Unique Individual Mutation: A Case Study in Batten's Disease
Session Chair(s)
Arthur M. Krieg, MD
CEO and CSO
Checkmate Pharmaceuticals, United States
Breakfast Plenary Session: Emergency Single Patient IND for Oligonucleotide Therapy of a Unique Individual Mutation: A Case Study in Batten's Disease
Speaker(s)
Speaker
Timothy W. Yu, MD, PhD
Boston Children’s Hospital, United States
Associate Professor, Harvard Medical School; Division of Genetics and Genomics